- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2013
- Public Summary Document (PSD) July 2013 PBAC Meeting - PDF
Linezolid – July 2013
Linezolid, injection, 600 mg per 300 mL, tablet, 600 mg and powder for oral suspension, 20 mg per mL, Zyvox®
Last updated
8 November 2023